Fintel reports that on September 21, 2023, Barclays initiated coverage of Organon (NYSE:OGN) with a Overweight recommendation.
Fintel reports that on September 21, 2023, Barclays initiated coverage of Organon (NYSE:OGN) with a Overweight recommendation.